Experts question Cambridge biotech’s strategy after trial failure

Wave Life Sciences took its first steps this week after a major corporate setback, releasing early data on one of the two potential treatments for Huntington’s disease, which it’s developing with Takeda Pharmaceutical Co. Ltd. The drugs are now Wave’s most advanced products in development following its decision earlier this month to halt testing on…

Read More

Newton REIT to change name in the new year

Senior Housing Properties Trust will change its name on Jan. 1, in a move the REIT says "more accurately depicts both our portfolio of diverse, high-quality healthcare real estate and our strategy moving forward." Read More

Read More